Functional effects of mutations in cytochrome c oxidase related to prostate cancer.
暂无分享,去创建一个
[1] R. Greenspan,et al. Neurogenetics , 2019, Journal of the Neurological Sciences.
[2] R. Gennis,et al. A pathogenic mutation in cytochrome c oxidase results in impaired proton pumping while retaining O(2)-reduction activity. , 2010, Biochimica et biophysica acta.
[3] Robert W. Taylor,et al. Mitochondrial DNA mutations and human disease. , 2010, Biochimica et biophysica acta.
[4] Laura C. Greaves,et al. Mitochondrial DNA mutations and ageing. , 2009, Biochimica et biophysica acta.
[5] Yidong Bai,et al. Implications of mitochondrial DNA mutations and mitochondrial dysfunction in tumorigenesis , 2009, Cell Research.
[6] P. Brzezinski,et al. A mitochondrial DNA mutation linked to colon cancer results in proton leaks in cytochrome c oxidase , 2009, Proceedings of the National Academy of Sciences.
[7] H. Fukui,et al. The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis? , 2008, Trends in Neurosciences.
[8] Hirokazu Fukui,et al. Cytochrome c oxidase deficiency in neurons decreases both oxidative stress and amyloid formation in a mouse model of Alzheimer's disease , 2007, Proceedings of the National Academy of Sciences.
[9] P. Brzezinski,et al. The inside pH determines rates of electron and proton transfer in vesicle-reconstituted cytochrome c oxidase. , 2007, Biochimica et biophysica acta.
[10] M. Suematsu,et al. The proton pumping pathway of bovine heart cytochrome c oxidase , 2007, Proceedings of the National Academy of Sciences.
[11] Anne Mulichak,et al. Identification of conserved lipid/detergent-binding sites in a high-resolution structure of the membrane protein cytochrome c oxidase , 2006, Proceedings of the National Academy of Sciences.
[12] A. Chatterjee,et al. Mitochondrial DNA mutations in human cancer , 2006, Oncogene.
[13] J. Enríquez,et al. m.6267G>A: a recurrent mutation in the human mitochondrial DNA that reduces cytochrome c oxidase activity and is associated with tumors , 2006, Human mutation.
[14] R. Carrozzo,et al. Introducing a novel human mtDNA mutation into the Paracoccus denitrificans COX I gene explains functional deficits in a patient , 2006, Neurogenetics.
[15] Robert W. Taylor,et al. Mitochondrial DNA mutations in human disease , 2005, Nature Reviews Genetics.
[16] Robert S. Balaban,et al. Mitochondria, Oxidants, and Aging , 2005, Cell.
[17] John A. Hall,et al. mtDNA mutations increase tumorigenicity in prostate cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[18] M. Bratton,et al. Disease-related mutations in cytochrome c oxidase studied in yeast and bacterial models. , 2003, European journal of biochemistry.
[19] S. Iwata,et al. The X-ray crystal structures of wild-type and EQ(I-286) mutant cytochrome c oxidases from Rhodobacter sphaeroides. , 2002, Journal of molecular biology.
[20] J. Taanman,et al. Mutations of cytochrome c oxidase subunits 1 and 3 in Saccharomyces cerevisiae: assembly defect and compensation. , 2002, Biochimica et biophysica acta.
[21] S. Nomoto,et al. Mitochondrial mutations in early stage prostate cancer and bodily fluids , 2001, Oncogene.
[22] B. Meunier. Site-directed mutations in the mitochondrially encoded subunits I and III of yeast cytochrome oxidase. , 2001, The Biochemical journal.
[23] G Parmigiani,et al. Detection of mitochondrial DNA mutations in pancreatic cancer offers a "mass"-ive advantage over detection of nuclear DNA mutations. , 2001, Cancer research.
[24] M. Saraste,et al. FEBS Lett , 2000 .
[25] R. Gennis,et al. Aspartate-132 in cytochrome c oxidase from Rhodobacter sphaeroides is involved in a two-step proton transfer during oxo-ferryl formation. , 1999, Biochemistry.
[26] M. Wikström,et al. Assignment and charge translocation stoichiometries of the major electrogenic phases in the reaction of cytochrome c oxidase with dioxygen. , 1999, Biochemistry.
[27] P. Brzezinski,et al. Factors determining electron-transfer rates in cytochrome c oxidase: investigation of the oxygen reaction in the R. sphaeroides enzyme. , 1998, Biochimica et biophysica acta.
[28] M. Mather,et al. Intrinsic uncoupling of cytochrome c oxidase may cause the maternally inherited mitochondrial diseases MELAS and LHON , 1998, FEBS letters.
[29] S. Ferguson-Miller,et al. Overexpression and purification of cytochrome c oxidase from Rhodobacter sphaeroides. , 1998, Protein expression and purification.
[30] S. Ferguson-Miller,et al. Heme/Copper Terminal Oxidases. , 1996, Chemical reviews.
[31] T. Tomizaki,et al. The Whole Structure of the 13-Subunit Oxidized Cytochrome c Oxidase at 2.8 Å , 1996, Science.
[32] Hartmut Michel,et al. Structure at 2.8 Å resolution of cytochrome c oxidase from Paracoccus denitrificans , 1995, Nature.
[33] R. Gennis,et al. Rapid purification of wildtype and mutant cytochrome c oxidase from Rhodobacter sphaeroides by Ni2+‐NTA affinity chromatography , 1995, FEBS letters.
[34] A. Revzin,et al. Cytochrome aa3 of Rhodobacter sphaeroides as a model for mitochondrial cytochrome c oxidase. The coxII/coxIII operon codes for structural and assembly proteins homologous to those in yeast. , 1992, The Journal of biological chemistry.
[35] E. Kandel,et al. Proceedings of the National Academy of Sciences of the United States of America. Annual subject and author indexes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[36] D. Kobayashi,et al. Improved broad-host-range plasmids for DNA cloning in gram-negative bacteria. , 1988, Gene.
[37] H. J. Gamble. Trends in Neurosciences , 1980 .
[38] W. E. Gye,et al. CANCER RESEARCH , 1923, British medical journal.